Last reviewed · How we verify
Placebo of Iron Carboxymaltose — Competitive Intelligence Brief
phase 3
Hematology
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of Iron Carboxymaltose (Placebo of Iron Carboxymaltose) — Hospital de Clinicas de Porto Alegre. This is a placebo control arm and contains no active pharmaceutical ingredient.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of Iron Carboxymaltose TARGET | Placebo of Iron Carboxymaltose | Hospital de Clinicas de Porto Alegre | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of Iron Carboxymaltose CI watch — RSS
- Placebo of Iron Carboxymaltose CI watch — Atom
- Placebo of Iron Carboxymaltose CI watch — JSON
- Placebo of Iron Carboxymaltose alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of Iron Carboxymaltose — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-iron-carboxymaltose. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab